ACTH(1‐24) was approved by the US FDA as a diagnostic agent for adrenal function test, whilst NDP‐MSH was approved by EMA for the treatment of erythropoietic protoporphyria. The gene discussed is POMC; the disease is erythropoietic protoporphyria.